Get started
Author

Christopher J. Roy

Observed names: C. Roy, Christopher Roy
ORCID: 0000-0002-4686-749X
Observed ORCID: 0000-0002-4686-749X
OpenAlex ID: A5102804892
Murine CD1d-Restricted T Cell Recognition of Cellular Lipids
2000 · Jenny E Gumperz, Christopher Roy, et al. · Immunity · 481
PDF
Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration
2018 · Amine Meliani, Florence Boisgerault, et al. · Nature Communications · 273
PDF
Enhancement of liver-directed transgene expression at initial and repeat doses of AAV vectors admixed with ImmTOR nanoparticles
2021 · Petr O. Ilyinskii, Alicia M. Michaud, et al. · Science Advances · 61
ImmTOR nanoparticles enhance AAV transgene expression after initial and repeat dosing in a mouse model of methylmalonic acidemia
2021 · Petr O. Ilyinskii, Alicia M. Michaud, et al. · Molecular Therapy — Methods & Clinical Development · 46
PDF
Rapamycin nanoparticles increase the therapeutic window of engineered interleukin-2 and drive expansion of antigen-specific regulatory T cells for protection against autoimmune disease
2023 · Takashi Kei Kishimoto, Max Fournier, et al. · Journal of Autoimmunity · 38
Enhancement of the Tolerogenic Phenotype in the Liver by ImmTOR Nanoparticles
2021 · Petr O. Ilyinskii, Christopher J. Roy, et al. · Frontiers in Immunology · 30
PDF
Readministration of high-dose adeno-associated virus gene therapy vectors enabled by ImmTOR nanoparticles combined with B cell-targeted agents
2023 · Petr O Ilyinskii, Christopher Roy, et al. · PNAS Nexus · 20
PDF
Op0002 Immtor Nanoparticles Enhance the Tolerogenic Environment of the Liver in Mice
2021 · P. Ilyinskii, C. Roy, et al. · Annals of the Rheumatic Diseases
PDF
Works count: 8
Citation count: 949
H-index: 7
I10-index: 7
Year
Topic
Type